Erratum: Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

doi:10.1002/cncr.26657

Erratum: Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

Cancer ◽

10.1002/cncr.26657 ◽

2011 ◽

Vol 118 (13) ◽

pp. 3446-3446

Keyword(s):

Elderly Patients ◽

B Cell ◽

Hodgkin Lymphoma ◽

Very Elderly ◽

Non Hodgkin Lymphoma ◽

Large B Cell

Download Full-text

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

Cancer ◽

10.1002/cncr.25582 ◽

2010 ◽

Vol 117 (5) ◽

pp. 964-973 ◽

Cited By ~ 32

Author(s):

Antonino Musolino ◽

Daniela Boggiani ◽

Michele Panebianco ◽

Giovanna Vasini ◽

Stefania Salvagni ◽

...

Keyword(s):

Elderly Patients ◽

B Cell ◽

Hodgkin Lymphoma ◽

Very Elderly ◽

Non Hodgkin Lymphoma ◽

Large B Cell

Download Full-text

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

Cancer ◽

10.1002/cncr.25948 ◽

2011 ◽

Vol 117 (15) ◽

pp. 3530-3530

Author(s):

Alberto Febbri ◽

Alessandro Gozzetti ◽

Luigi Rigacci

Keyword(s):

Elderly Patients ◽

B Cell ◽

Hodgkin Lymphoma ◽

Very Elderly ◽

Non Hodgkin Lymphoma ◽

Large B Cell

Download Full-text

Reply to activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

Cancer ◽

10.1002/cncr.25962 ◽

2011 ◽

Vol 117 (15) ◽

pp. 3531-3531

Author(s):

Antonino Musolino ◽

Daniela Boggiani ◽

Michele Panebianco

Keyword(s):

Elderly Patients ◽

B Cell ◽

Hodgkin Lymphoma ◽

Very Elderly ◽

Non Hodgkin Lymphoma ◽

Large B Cell

Download Full-text

Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapy

International Journal of Clinical Oncology ◽

10.1007/s10147-015-0912-6 ◽

2015 ◽

Vol 21 (3) ◽

pp. 498-505 ◽

Cited By ~ 12

Author(s):

Futoshi Iioka ◽

Kiyotaka Izumi ◽

Yoshimasa Kamoda ◽

Takashi Akasaka ◽

Hitoshi Ohno

Keyword(s):

Elderly Patients ◽

B Cell ◽

Hodgkin Lymphoma ◽

Very Elderly ◽

Reduced Dose ◽

Non Hodgkin Lymphoma

Download Full-text

Phase II Trial of TisaGenlecleucel (Kymriah®) in Elderly Patients With First-Relapsed or Primary Refractory Agressive B-cell Non-Hodgkin Lymphoma

Case Medical Research ◽

10.31525/ct1-nct04161118 ◽

2019 ◽

Author(s):

Keyword(s):

Elderly Patients ◽

B Cell ◽

Hodgkin Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Non Hodgkin Lymphoma

Download Full-text

One Year of Maintenance Metronomic Cyclophosphamide, Methotreaxate & Celecoxib in High Risk Diffuse Large B Cell Non Hodgkin Lymphoma After Complete Response.

Research in Oncology ◽

10.21608/resoncol.2014.882 ◽

2014 ◽

Vol 10 (Issue 1-2) ◽

pp. 40-45

Author(s):

S. AlHassanin ◽

T. Hashem ◽

K. ElDin ◽

H. Kohail ◽

H. ElSheridy ◽

...

Keyword(s):

High Risk ◽

B Cell ◽

Hodgkin Lymphoma ◽

Complete Response ◽

Non Hodgkin Lymphoma ◽

One Year ◽

Metronomic Cyclophosphamide ◽

Large B Cell

Download Full-text

Acute tumor lysis syndrome in large B-cell non-Hodgkin lymphoma induced by steroids and anti-CD 20

The Hematology Journal ◽

10.1038/sj.thj.6200244 ◽

2003 ◽

Vol 4 (3) ◽

pp. 222-224 ◽

Cited By ~ 14

Author(s):

Yasser Abou Mourad ◽

Ali Taher ◽

Ali Shamseddine

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Tumor Lysis Syndrome ◽

Tumor Lysis ◽

Non Hodgkin Lymphoma ◽

Large B Cell

Download Full-text

Pathway activation in large B-cell non-Hodgkin lymphoma cell lines by doxorubicin reveals prognostic markers ofin vivoresponse

Leukemia & Lymphoma ◽

10.1080/10428190802428369 ◽

2008 ◽

Vol 49 (11) ◽

pp. 2170-2180 ◽

Cited By ~ 10

Author(s):

Jane Houldsworth ◽

Marina Petlakh ◽

Adam B. Olshen ◽

R. S. K. Chaganti

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Cell Lines ◽

Prognostic Markers ◽

Lymphoma Cell ◽

Non Hodgkin Lymphoma ◽

Pathway Activation ◽

Hodgkin Lymphoma Cell ◽

Large B Cell

Download Full-text

Diffuse Large B-cell Lymphoma in Very Elderly Patients: towards Best Tailored Treatment – a Systematic Review

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2021.103294 ◽

2021 ◽

pp. 103294

Author(s):

Alda Tavares ◽

Ilídia Moreira

Keyword(s):

Systematic Review ◽

Elderly Patients ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Very Elderly ◽

Tailored Treatment ◽

Large B Cell Lymphoma ◽

Large B Cell

Download Full-text

Diffuse large B-cell non-Hodgkin lymphoma

Cancers in the Urban Environment ◽

10.1016/b978-0-12-811745-3.00106-3 ◽

2021 ◽

pp. 837-849

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Non Hodgkin Lymphoma ◽

Large B Cell

Download Full-text